Lindbrook Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.81K | Sell |
210
-62
| -23% | -$1.13K | ﹤0.01% | 2066 |
|
|
2024
Q4 | $6.87K | Buy |
272
+107
| +65% | +$2.7K | ﹤0.01% | 1836 |
|
|
2024
Q3 | $5.61K | Buy |
165
+10
| +6% | +$340 | ﹤0.01% | 1968 |
|
|
2024
Q2 | $5.74K | Hold |
155
| – | – | ﹤0.01% | 1934 |
|
|
2024
Q1 | $6.51K | Hold |
155
| – | – | ﹤0.01% | 1780 |
|
|
2023
Q4 | $6.15K | Buy |
+155
| New | +$6.15K | ﹤0.01% | 1775 |
|
|
2023
Q3 | – | Sell |
-54
| Closed | -$1.83K | – | 2712 |
|
|
2023
Q2 | $1.83K | Buy |
54
+11
| +26% | +$373 | ﹤0.01% | 2178 |
|
|
2023
Q1 | $1.55K | Sell |
43
-36
| -46% | -$1.3K | ﹤0.01% | 2344 |
|
|
2022
Q4 | $3.52K | Buy |
79
+76
| +2,533% | +$3.39K | ﹤0.01% | 1983 |
|
|
2022
Q3 | $0 | Sell |
3
-6
| -67% | – | ﹤0.01% | 2659 |
|
|
2022
Q2 | $0 | Sell |
9
-43
| -83% | – | ﹤0.01% | 2526 |
|
|
2022
Q1 | $2K | Buy |
+52
| New | +$2K | ﹤0.01% | 1962 |
|
|
2021
Q4 | – | Sell |
-990
| Closed | -$53K | – | 2089 |
|
|
2021
Q3 | $53K | Buy |
+990
| New | +$53K | 0.01% | 420 |
|
|
2021
Q2 | – | Sell |
-1,000
| Closed | -$21K | – | 1920 |
|
|
2021
Q1 | $21K | Buy |
+1,000
| New | +$21K | ﹤0.01% | 733 |
|
|
2020
Q3 | – | Sell |
-1,618
| Closed | -$21K | – | 1755 |
|
|
2020
Q2 | $21K | Buy |
+1,618
| New | +$21K | 0.01% | 587 |
|